GAMMA Investing LLC Buys 267 Shares of Trupanion, Inc. (NASDAQ:TRUP)

GAMMA Investing LLC increased its position in Trupanion, Inc. (NASDAQ:TRUP) by 18.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,709 shares of the financial services provider’s stock after buying an additional 267 shares during the period. GAMMA Investing LLC’s holdings in Trupanion were worth $82,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in TRUP. FMR LLC grew its stake in Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after acquiring an additional 1,170,202 shares during the period. Renaissance Technologies LLC bought a new position in shares of Trupanion in the 2nd quarter worth $4,739,000. Marshall Wace LLP grew its position in Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after purchasing an additional 116,496 shares during the period. Connors Investor Services Inc. increased its stake in Trupanion by 31.3% during the 2nd quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock valued at $3,339,000 after purchasing an additional 27,042 shares in the last quarter. Finally, Dalton Investments Inc. acquired a new position in Trupanion during the second quarter worth $1,029,000.

Insider Buying and Selling

In other Trupanion news, EVP Steve Weinrauch sold 11,916 shares of the business’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $53.00, for a total value of $631,548.00. Following the sale, the executive vice president now directly owns 48,978 shares in the company, valued at $2,595,834. The trade was a 19.57 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 9,867 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $53.08, for a total value of $523,740.36. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 28,597 shares of company stock worth $1,522,082. Insiders own 5.50% of the company’s stock.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $43.95 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $1.86 billion, a PE ratio of -137.34 and a beta of 1.61. The stock’s 50 day moving average price is $51.43 and its 200-day moving average price is $44.97. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The business’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.10) EPS. On average, equities analysts anticipate that Trupanion, Inc. will post -0.23 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have weighed in on TRUP shares. Bank of America raised their price objective on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Stifel Nicolaus lifted their price target on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Piper Sandler boosted their price objective on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Finally, Northland Securities raised their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Trupanion currently has an average rating of “Moderate Buy” and a consensus price target of $45.33.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.